共 145 条
[1]
Zaman SN(1985)Risk factors in development of hepatocellular carcinoma in cirrhosis: Prospective study of 613 patients Lancet 1 1357-1360
[2]
Melia WM(1991)Hepatocellular carcinoma in Italian patients with cirrhosis N Engl J Med 325 675-680
[3]
Johnson RD(1992)Hepatitis C virus infection as a risk factor for hepatocellular carcinoma in patients with cirrhosis. A case–control study Ann Intern Med 116 97-102
[4]
Colombo M(2002)Effect of hepatitis B and C virus infections on the natural history of compensated cirrhosis: A cohort study of 297 patients Am J Gastroenterol 97 2886-2895
[5]
de Franchis R(2004)Natural history of compensated viral cirrhosis: A prospective study on the incidence and hierarchy of major complications Gut 53 744-749
[6]
Del Ninno E(2006)The natural history of compensated cirrhosis due to hepatitis C virus: A 17-year cohort study of 214 patients Hepatology 43 1303-1310
[7]
Simonetti RS(2006)A sustained virological response to interferon or interferon/ribavirin reduces hepatocellular carcinoma and improves survival in chronic hepatitis C: A nationwide, multicentre study in Taiwan Antivir Ther 11 985-994
[8]
Cammà C(1999)Interferon therapy lowers the rate of progression to hepatocellular carcinoma in chronic hepatitis C but not significantly in an advanced stage: A retrospective study in 1148 patients. Viral Hepatitis Therapy Study Group J Hepatol 30 653-659
[9]
Fiorello F(1999)Interferon therapy reduces the risk for hepatocellular carcinoma: National surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan. IHIT Study Group. Inhibition of Hepatocarcinogenesis by Interferon Therapy Ann Intern Med 131 174-181
[10]
Fattovich G(2005)Antiviral therapy for cirrhotic hepatitis C: Association with reduced hepatocellular carcinoma development and improved survival Ann Intern Med 142 105-114